Short-Term Hyperthermia Promotes the Sensitivity of MCF-7 Human Breast Cancer Cells to Paclitaxel
-
- Lin Yan
- Department of First Chemotherapy, Affiliated Cancer Hospital of Guangxi Medical University
-
- Liu Zhihui
- Department of First Chemotherapy, Affiliated Cancer Hospital of Guangxi Medical University
-
- Li Yongqiang
- Department of First Chemotherapy, Affiliated Cancer Hospital of Guangxi Medical University
-
- Liao Xiaoli
- Department of First Chemotherapy, Affiliated Cancer Hospital of Guangxi Medical University
-
- Liao Sina
- Department of First Chemotherapy, Affiliated Cancer Hospital of Guangxi Medical University
-
- Cen Shaofang
- Department of First Chemotherapy, Affiliated Cancer Hospital of Guangxi Medical University
-
- Yang Ling
- Department of First Chemotherapy, Affiliated Cancer Hospital of Guangxi Medical University
-
- Wei Jiazhang
- Department of Clinical Pharmacology and Therapeutics, School of Medicine, Hamamatsu University
-
- Hu Xiaohua
- Department of First Chemotherapy, Affiliated Cancer Hospital of Guangxi Medical University
この論文をさがす
抄録
As a physical adjuvant approach in the treatment of solid tumors, regional hyperthermia plays a synergistic role in enhancing the efficacy of simultaneous chemotherapy. Paclitaxel (PTX) is an anti-mitotic taxane drug that is widely used in chemotherapy for the treatment of various human malignancies such as lung, ovarian, breast, and head and neck cancers. Since the possibility that hyperthermia can enhance the anti-tumor effects of PTX has not yet been investigated, the present study was designed to evaluate the effects of short-term hyperthermia on PTX-induced antitumor activity in the human breast cancer line MCF-7. It was found that short-term hyperthermia promoted PTX-induced suppression of cell proliferation. The IC50 for PTX was reduced from 18.2±1.0 to 15.0±0.45 nM (p<0.05). The level of PTX-induced cell apoptosis was increased from 8.5±1.2 to 16.4±2.4% (p<0.05) and from 15.2±1.4 to 34.9±2.8% (p<0.05), at the end of the first and second hyperthermia cycles, respectively; both the activity and expression of caspase-7 were enhanced. In addition, PTX-induced cell cycle arrest in the G2/M phase was further promoted by short-term hyperthermia, from 9.3±0.7 to 12.5±0.9% (p<0.05). In contrast, short-term hyperthermia affected neither tumor cell migration nor invasion in the presence or absence of PTX. The presented data thus suggest that short-term hyperthermia may serve as a feasible approach in the promotion of breast cancer cell sensitivity to PTX.
収録刊行物
-
- Biological & Pharmaceutical Bulletin
-
Biological & Pharmaceutical Bulletin 36 (3), 376-383, 2013
公益社団法人 日本薬学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390001204634146176
-
- NII論文ID
- 130002480764
-
- NII書誌ID
- AA10885497
-
- COI
- 1:STN:280:DC%2BC3s3gtFOgsA%3D%3D
-
- ISSN
- 13475215
- 09186158
-
- NDL書誌ID
- 024283749
-
- PubMed
- 23229357
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可